Found: 48
Select item for more details and to access through your institution.
The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.
- Published in:
- 2008
- By:
- Publication type:
- journal article
The Significance of Anemia in Elderly Patients with Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 100
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12669-5
- By:
- Publication type:
- Article
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-019-0835-1
- By:
- Publication type:
- Article
Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16588-3
- By:
- Publication type:
- Article
Managing Cardiac Risk Factors in Oncology Clinical Trials.
- Published in:
- Texas Heart Institute Journal, 2011, v. 38, n. 3, p. 266
- By:
- Publication type:
- Article
Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211001538
- By:
- Publication type:
- Article
Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211001538
- By:
- Publication type:
- Article
Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1836, doi. 10.1111/bcp.14289
- By:
- Publication type:
- Article
Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1330, doi. 10.3390/cancers14051330
- By:
- Publication type:
- Article
Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 2, p. 340, doi. 10.1002/cam4.4446
- By:
- Publication type:
- Article
A phase I study of fludarabine, cytarabine, and oxaliplatin therapy in patients with relapsed or refractory acute myeloid leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Hodgkin transformation of chronic lymphocytic leukemia: The M. D. Anderson Cancer Center experience.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 6, p. 1294
- By:
- Publication type:
- Article
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 2, p. 345, doi. 10.1002/cncr.21151
- By:
- Publication type:
- Article
Richter syndrome: Biology, incidence, and therapeutic strategies.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 2, p. 216
- By:
- Publication type:
- Article
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 10, p. 2195
- By:
- Publication type:
- Article
Activity of interferon-α and isotretinoin in patients with advanced, refractory lymphoid malignancies.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 3, p. 574
- By:
- Publication type:
- Article
Phase II study of pentostatin in advanced T-cell lymphoid malignancies.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 2, p. 342
- By:
- Publication type:
- Article
Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia (The following Hospitals and Physicians participated in the study: First Department of Internal Medicine, National University of Athens, Medical School, Laiko General Hospital (D. Loukopoulos, A. M. Tsimberidou, N. Viniou, N. Stavroyianni, J. Meletis, C. Constantopoulos, E. Variami, T. Andreopoulos, Y. Rombos, and X. Yataganas); Department of Clinical Propedeutic National University of Athens Medical School, Laiko General Hospital (P. Panagiotidis); Second Department of Internal Medicine, National University of Athens Medical School, Hippokration General Hospital (Th. Kalmantis and M. Belegrati); Department of Internal Medicine, Division of Hematology,University Hospital of Patras, Rion-Patras (N. Zoumbos, T. Matsouka, M. Tin)
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 7, p. 1721, doi. 10.1002/cncr.11240
- By:
- Publication type:
- Article
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 2, p. 107, doi. 10.1007/s00280-023-04545-4
- By:
- Publication type:
- Article
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Targeted therapy in cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Lenalidomide in solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1393, doi. 10.1007/s00280-012-1874-2
- By:
- Publication type:
- Article
Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1507, doi. 10.1007/s00280-011-1635-7
- By:
- Publication type:
- Article
Phase 1 first-in-human clinical study of S- trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 235, doi. 10.1007/s00280-009-1027-4
- By:
- Publication type:
- Article
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 3, p. 237, doi. 10.1007/s00280-002-0479-6
- By:
- Publication type:
- Article
Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 266, doi. 10.1038/s41416-023-02280-4
- By:
- Publication type:
- Article
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: The M. D. Anderson Cancer Center experience.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 7, p. 408, doi. 10.1002/ajh.21423
- By:
- Publication type:
- Article
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00159-2
- By:
- Publication type:
- Article
AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology.
- Published in:
- Cell & Bioscience, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13578-022-00793-8
- By:
- Publication type:
- Article
Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phase 1 Clinical Trials in 83 Patients With Pancreatic Cancer.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 1, p. 77, doi. 10.1002/cncr.25346
- By:
- Publication type:
- Article
Treatment of Fludarabine-refractory Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 13, p. 2824, doi. 10.1002/cncr.24329
- By:
- Publication type:
- Article
Chemoimmunotherapy May Overcome the Adverse Prognostic Significance of 11q Deletion in Previously Untreated Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 2, p. 373, doi. 10.1002/cncr.23993
- By:
- Publication type:
- Article
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.
- Published in:
- 2008
- By:
- Publication type:
- journal article
The role of gemtuzumab ozogamicin in acute leukaemia therapy.
- Published in:
- British Journal of Haematology, 2006, v. 132, n. 4, p. 398, doi. 10.1111/j.1365-2141.2005.05872.x
- By:
- Publication type:
- Article
Metastatic extraneural glioblastoma diagnosed with molecular testing.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. 811, doi. 10.1093/oncolo/oyae115
- By:
- Publication type:
- Article
Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 558, doi. 10.1002/onco.13682
- By:
- Publication type:
- Article
Anti-Vascular Endothelial Growth Factor Therapies and Cardiovascular Toxicity: What Are the Important Clinical Markers to Target?
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 130, doi. 10.1634/theoncologist.2009-0252
- By:
- Publication type:
- Article
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01132-z
- By:
- Publication type:
- Article
T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, p. 1, doi. 10.1186/s13045-021-01115-0
- By:
- Publication type:
- Article
Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Richter’s transformation in chronic lymphocytic leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2007, v. 2, n. 4, p. 265, doi. 10.1007/s11899-007-0036-9
- By:
- Publication type:
- Article